Dena Sharp simplifies even the hardest issues in complex litigation. She currently serves as co-lead counsel in In re Xyrem Antitrust Litigation, In re Juul Labs Inc. multidistrict litigation, and In re California Gasoline Spot Market Antitrust Litigation. She also serves as co-lead counsel for a certified class in the In re Restasis Antitrust Litigation, and as a member of the End-Payer Steering Committee in the massive In re Generic Pharmaceuticals Pricing Antitrust Litigation. In addition, Dena is privileged to represent clients of a fertility center whose eggs and embryos were compromised by a freezer tank malfunction.

As co-lead counsel in In re Lidoderm Antitrust Litigation, a “pay-for delay” antitrust case that settled for $104.75 million on the eve of trial, Dena worked with her team to win class certification, defeat summary judgment, and obtain the largest recovery for a class of end-payers in similar federal litigation in more than a decade. She has also played a key role in a variety of other high-profile cases, including representing investors in litigation arising from Lehman Brothers’ bankruptcy and in matters involving Ponzi schemes and accounting fraud.

Outside the courtroom, Dena was elected to the American Law Institute in 2018 and is the current co-chair of the Lawyer Representatives to the Ninth Circuit Judicial Conference for the Northern District of California. Dena has served as co-chair and faculty member of the annual Judicial Training Symposium for Federal Judges, hosted by the Federal Judicial Center and the Electronic Discovery Institute. She sits on the board of directors of the Impact Fund, a public interest nonprofit, and serves as a vice chair of the Advisory Council for the Duke Law School Center for Judicial Studies. Dena also co-authored the widely-cited Sedona Principles: Best Practices and Principles for Electronic Document Production (Third Edition), and a chapter in the ABA’s “Class Action Strategy and Practice Guide.”

The National Law Journal has recognized Dena as an “Elite Woman of the Plaintiffs’ Bar” for two consecutive years, honoring her as one of only a handful of lawyers nationwide who has “consistently excelled in high-stakes matters on behalf of plaintiffs” over the course of her career. Dena was named one of the “Best Lawyers in America” in both 2021 and 2022, and one of the "Top 50 Women Attorneys in Northern California" by San Francisco Magazine in 2021. Dena has also been recognized as a Northern California Super Lawyer or Rising Star every year since 2009. 

Dena is a graduate, cum laude, of the University of California, Hastings College of Law, where she was a member of the Thurston Society and received the Best Oral Advocate and Witkin awards. She graduated magna cum laude from Brown University. During law school, Dena externed for the Honorable Phyllis J. Hamilton of the Northern District of California, and the Honorable John E. Munter of the San Francisco Superior Court. A first-generation American, Dena is fluent in Spanish and German.


  • Externed for the Honorable Phyllis J. Hamilton of the Northern District of California
  • Externed for the Honorable John E. Munter of the San Francisco Superior Court


J.D., cum laude, University of California, Hastings College of Law

  • Thurston Honors Society
  • Best Oral Advocate Award
  • Witkin Award in Legal Writing and Criminal Law courses

B.A., magna cum laude, Brown University


  • California
  • Northern District of California
  • Central District of California
  • Southern District of California
  • Eastern District of California
  • District of Colorado
  • Northern District of Illinois
  • Courts of Appeals for the Ninth and Tenth Circuits


  • Spanish
  • German


In re Restasis Antitrust Litigation
Co-lead counsel in this monopolization case against pharmaceutical giant Allergan for its multifaceted strategy to delay generic competition in the market for the blockbuster drug Restasis.

In re Lidoderm Antitrust Litigation
Co-lead counsel in this “pay-for-delay” litigation against three drug companies. Settled a week before jury selection only after the class was certified and summary judgment had been denied. The $104.75 million settlement represents the largest end-payer recovery in absolute and percentage terms in any federal pay-for-delay case in at least the past decade.

In re Generic Pharmaceuticals Pricing Antitrust Litigation
Member of the End-Payer Plaintiffs’ Steering Committee in this massive price-fixing case against dozens of drug companies, where executives have pleaded guilty to collusion and 48 state attorneys general have alleged a sprawling conspiracy on the part of the drug makers.

In re Pacific Fertility Litigation
Representing plaintiffs who allege their frozen eggs and embryos were affected by the failure of a cryopreservation tank at Pacific Fertility Center’s San Francisco clinic in early March 2018. 

In re Capacitors Antitrust Litigation
Representing direct purchasers in a multidistrict proceeding that follows several executives pleading guilty to fixing the prices of capacitors, tiny electronic components found in devices from toasters to cell phones. Nearly $100 million in settlements to date and the case is proceeding to trial.

In re Lehman Brothers Holdings Securities and ERISA Litigation
Lead counsel for investors in the securities litigation arising from the largest bankruptcy in United States history. Recovered $120 million on behalf of structured note investors and helped secure total recoveries of over $700 million.

In re Oppenheimer California Fund Securities Litigation
Co-lead counsel for investors in Oppenheimer’s California Municipal Bond Fund, which misled investors about its investment risk and then lost nearly half its value. Recovered $50.75 million for the certified class of investors.

In re Provident Royalties, LLC / Medical Capital
Lead counsel team for the plaintiffs in this Ponzi scheme litigation, ultimately recovering $150 million for investors.

In re SLM Corporation Securities Litigation
Lead counsel team in accounting fraud litigation brought under Rule 10b-5 that resulted in a $35 million recovery.

Honors and Awards

Honors and Awards

  • Named to the Northern California Super Lawyers list (2017-present)
  • Named to the Northern California Rising Stars list (2009-2016)
  • Named to Best Lawyers in America (2021)
  • Named one of the Top 50 Women Attorneys in Northern California (2021)
  • Named to the National Trial Lawyers Top 100 (2019)
  • Winner of the National Law Journal's Elite Women of the Plaintiff's Bar (2019, 2020)


Award plaque recognizing Dena Sharp as a Top 50 Women Attorney in Northern California


Community & Professional

  • Member, American Law Institute
  • Lawyer Representative, Ninth Circuit Judicial Council
  • Impact Fund 
    • Member, Board of Directors
    • Member, Grant Advisory Committee
    • Chair, Development Committee
  • Vice chair, Duke Law Bolch Judicial Institute, Advisory Council for the Duke Conferences
  • Member, The Sedona Conference, Working Group 1 on Electronic Document Retention and Production
  • American Bar Association
    • Member, Sections on Antitrust, Securities Litigation, and Pretrial Practice and Discovery
    • Former vice chair, Young Lawyer’s Division Litigation Committee 
  • Member, Federal Bar Association, Northern District of California Chapter
  • Member, State Bar of California, Litigation Section



Speaking Engagements


Main Menu